391 related articles for article (PubMed ID: 11944630)
1. Diabetes mellitus, obesity, and hepatic steatosis.
Youssef W; McCullough AJ
Semin Gastrointest Dis; 2002 Jan; 13(1):17-30. PubMed ID: 11944630
[TBL] [Abstract][Full Text] [Related]
2. Non-alcoholic steatohepatitis in children.
Nanda K
Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
[TBL] [Abstract][Full Text] [Related]
3. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease.
McCullough AJ
Clin Liver Dis; 2004 Aug; 8(3):521-33, viii. PubMed ID: 15331061
[TBL] [Abstract][Full Text] [Related]
4. Update on nonalcoholic fatty liver disease.
McCullough AJ
J Clin Gastroenterol; 2002 Mar; 34(3):255-62. PubMed ID: 11873108
[TBL] [Abstract][Full Text] [Related]
5. Obesity, hepatic metabolism and disease.
Edmison JM; Kalhan SC; McCullough AJ
Nestle Nutr Workshop Ser Pediatr Program; 2009; 63():163-72; discussion 172-6, 259-68. PubMed ID: 19346775
[TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic steatohepatitis.
Diehl AM
Semin Liver Dis; 1999; 19(2):221-9. PubMed ID: 10422202
[TBL] [Abstract][Full Text] [Related]
7. [Non-alcoholic fatty liver disease--new view].
Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic fatty liver disease.
Yu AS; Keeffe EB
Rev Gastroenterol Disord; 2002; 2(1):11-9. PubMed ID: 12122975
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic steatohepatitis.
Jansen PL
Neth J Med; 2004; 62(7):217-24. PubMed ID: 15554595
[TBL] [Abstract][Full Text] [Related]
10. Acarbose is a promising therapeutic strategy for the treatment of patients with nonalcoholic steatohepatitis (NASH).
Yamagishi S; Nakamura K; Inoue H
Med Hypotheses; 2005; 65(2):377-9. PubMed ID: 15922116
[TBL] [Abstract][Full Text] [Related]
11. [NASH -- nonalcoholic steatohepatitis].
Blechacz B; Stremmel W
Z Gastroenterol; 2003 Jan; 41(1):77-90. PubMed ID: 12541180
[TBL] [Abstract][Full Text] [Related]
12. Non-alcoholic steatohepatitis.
Das K; Kar P
J Assoc Physicians India; 2005 Mar; 53():195-9. PubMed ID: 15926603
[TBL] [Abstract][Full Text] [Related]
13. [Nonalcoholic steatohepatitis: pathogenesis and treatment].
Park SH
Korean J Hepatol; 2008 Mar; 14(1):12-27. PubMed ID: 18367854
[TBL] [Abstract][Full Text] [Related]
14. The emerging problem of nonalcoholic steatohepatitis (NASH).
Portincasa P; Grattagliano I; Palmieri VO; Palasciano G
Rom J Gastroenterol; 2005 Mar; 14(1):43-51. PubMed ID: 15800693
[TBL] [Abstract][Full Text] [Related]
15. The treatment of NAFLD.
Trappoliere M; Tuccillo C; Federico A; Di Leva A; Niosi M; D'Alessio C; Capasso R; Coppola F; Dauria M; Loguercio C
Eur Rev Med Pharmacol Sci; 2005; 9(5):299-304. PubMed ID: 16231594
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic steatohepatitis: what we know in the new millennium.
Harrison SA; Kadakia S; Lang KA; Schenker S
Am J Gastroenterol; 2002 Nov; 97(11):2714-24. PubMed ID: 12425538
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis and therapy in NASH].
Tokushige K
Rinsho Byori; 2009 Sep; 57(9):848-53. PubMed ID: 19860210
[TBL] [Abstract][Full Text] [Related]
18. [Nonalcoholic steatohepatitis in children].
Cubelić S; Misak Z; Gasparov S; Kolacek S
Lijec Vjesn; 2004; 126(7-8):197-200. PubMed ID: 15754789
[TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease.
Yalamanchili K; Saadeh S; Klintmalm GB; Jennings LW; Davis GL
Liver Transpl; 2010 Apr; 16(4):431-9. PubMed ID: 20373454
[TBL] [Abstract][Full Text] [Related]
20. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
